National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.

@article{Ehlers2008NationalUO,
  title={National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark: a model of budgetary impact and cost effectiveness.},
  author={Lars Ehlers and Wilhelmina Maria M{\"u}skens and Lotte Groth Jensen and Mette Kj\olby and Grethe Andersen},
  journal={CNS drugs},
  year={2008},
  volume={22 1},
  pages={73-81}
}
AIM The purpose of this analysis was to assess the budgetary impact and cost effectiveness of the national use of thrombolysis with alteplase (recombinant tissue plasminogen activator; rt-PA) for acute ischaemic stroke via telemedicine in Denmark. METHODS Computations were based on a Danish health economic model of thrombolysis treatment of acute ischaemic stroke via telemedicine. Cost data for stroke units and satellite clinics were taken from the first practical experiences in Denmark with… CONTINUE READING
15 Citations
2 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-2 of 2 references

Cost - effectiveness of intravenous thrombolysis with alteplase within a 3 - hour window after acute ischemic

  • P Sandercock, E Berge, M Dennis
  • STROKE

National use of thrombolysis with alteplase for acute ischaemic stroke via telemedicine in Denmark : a model of budgetary impact and cost effectiveness

  • L Ehlers, G Andersen, LB Clausen

Similar Papers

Loading similar papers…